BLFS EBITDA Margin
Biolife Solutions Inc · EBITDA Margin
BLFS EBITDA Margin
Latest reported9.37%period ending
BLFS TTM EBITDA Margin (-100.00% → 9.37%)
TTM ebitda margin
High-resolution chart · PNG
BLFS ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 9.37% | |
| -8.2768% | |
| -9.165% | |
| -8.3386% | |
| -8.5794% | |
| 12.4599% | |
| 12.0867% | |
| -2.4415% | |
| -16.191% | |
| -17.3338% | |
| -22.1427% | |
| -23.4997% | |
| -17.3081% | |
| -59.2642% | |
| -55.6587% | |
| -60.0601% | |
| -63.354% | |
| -15.2459% | |
| -13.9011% | |
| -12.6686% | |
| -6.5194% | |
| -10.2384% | |
| -10.4103% | |
| -26.9085% | |
| -1.4386% | |
| 12.0727% | |
| 10.855% | |
| 68.3972% | |
| 31.4355% | |
| 18.6903% | |
| 18.971% | |
| 13.0805% | |
| 4.8296% | |
| -8.0963% | |
| -16.617% | |
| -46.1032% | |
| -59.9143% | |
| -75.0999% | |
| -89.4789% | |
| -68.7075% | |
| -74.4325% | |
| -73.4127% | |
| -72.391% | |
| -67.8656% | |
| -65.5852% | |
| -64.6817% | |
| -46.3424% | |
| -31.8137% | |
| -18.0994% | |
| -6.8887% | |
| -0.7413% | |
| -1.4687% | |
| -2.4189% | |
| -6.3527% | |
| -13.6429% | |
| -15.8534% | |
| -25.0923% | |
| -27.9332% | |
| -43.0828% | |
| -50.3117% | |
| -53.6435% | |
| -62.9779% | |
| -63.2505% | |
| -61.4198% | |
| -71.3482% | |
| -108.1571% | |
| -138.5038% | |
| -0.2052% | |
| -0.2184% | |
| -0.1976% | |
| -0.1847% | |
| -0.2436% | |
| -0.2568% | |
| -0.2704% | |
| -0.2728% | |
| -0.4043% | |
| -0.35% | |
| -0.3024% | |
| -0.2395% | |
| -185.9674% | |
| -139.3829% | |
| -94.788% | |
| -91.3333% | |
| -67.3282% | |
| -67.3123% | |
| -84.2812% | |
| -78.5404% | |
| -107.3233% | |
| -167.9578% | |
| -248.4998% | |
| -188.2521% | |
| -147.7933% | |
| -105.1109% | |
| -54.6727% | |
| -57.1998% | |
| -130.2022% | |
| 72.5497% | |
| 73.2422% | |
| -19.8399% | |
| -39.449% |